United Therapeutics Corp.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $565.7M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $83.0M | 14.7% |
| Other Investing | $414.5M | 73.3% |
| Working Capital | $48.2M | 8.5% |
| Other | $20.0M | 3.5% |
| Net Cash Flow | $0 | 0.0% |